These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 32531979)

  • 1. Idiosyncratic Drug-Induced Neutropenia and Agranulocytosis in Elderly Patients.
    Lorenzo-Villalba N; Alonso-Ortiz MB; Maouche Y; Zulfiqar AA; Andrès E
    J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32531979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Life-threatening idiosyncratic drug-induced agranulocytosis in elderly patients.
    Andrès E; Noel E; Kurtz JE; Henoun Loukili N; Kaltenbach G; Maloisel F
    Drugs Aging; 2004; 21(7):427-35. PubMed ID: 15132711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies.
    Andrès E; Villalba NL; Zulfiqar AA; Serraj K; Mourot-Cottet R; Gottenberg AJ
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31480527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiosyncratic drug-induced agranulocytosis or acute neutropenia.
    Andrès E; Maloisel F
    Curr Opin Hematol; 2008 Jan; 15(1):15-21. PubMed ID: 18043241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases.
    Mourot-Cottet R; Maloisel F; Séverac F; Keller O; Vogel T; Tebacher M; Weber JC; Kaltenbach G; Gottenberg JE; Goichot B; Sibilia J; Korganow AS; Herbrecht R; Andrès E
    Drugs Real World Outcomes; 2016 Dec; 3(4):393-399. PubMed ID: 27747601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idiosyncratic drug-induced neutropenia & agranulocytosis.
    Andrès E; Mourot-Cottet R; Maloisel F; Séverac F; Keller O; Vogel T; Tebacher M; Weber JC; Kaltenbach G; Gottenberg JE; Goichot B; Sibilia J; Korganow AS; Herbrecht R
    QJM; 2017 May; 110(5):299-305. PubMed ID: 28069912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Idiosyncratic drug-induced agranulocytosis].
    Andrès E; Maloisel F;
    Rev Med Interne; 2006 Mar; 27(3):209-14. PubMed ID: 16043267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiosyncratic drug-induced agranulocytosis: Update of an old disorder.
    Andrès E; Zimmer J; Affenberger S; Federici L; Alt M; Maloisel F
    Eur J Intern Med; 2006 Dec; 17(8):529-35. PubMed ID: 17142169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-chemotherapy drug-induced neutropenia - an update.
    Andrès E; Mourot-Cottet R
    Expert Opin Drug Saf; 2017 Nov; 16(11):1235-1242. PubMed ID: 28879784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-chemotherapy drug-induced agranulocytosis.
    Garbe E
    Expert Opin Drug Saf; 2007 May; 6(3):323-35. PubMed ID: 17480181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs.
    Andrès E; Mourot-Cottet R; Maloisel F; Keller O; Vogel T; Séverac F; Tebacher M; Gottenberg JE; Weber JC; Kaltenbach G; Goichot B; Sibilia J; Korganow AS; Herbrecht R
    J Clin Med; 2017 Sep; 6(10):. PubMed ID: 28954408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center.
    Andrès E; Lorenzo Villalba N; Mourot-Cottet R; Maloisel F; Tebacher M; Gottenberg JE; Goichot B; Herbrecht R; Zulfiqar AA
    Medicines (Basel); 2020 Mar; 7(3):. PubMed ID: 32204561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis.
    Andrès E; Federici L; Weitten T; Vogel T; Alt M
    Expert Opin Drug Saf; 2008 Jul; 7(4):481-9. PubMed ID: 18613811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Idiosyncratic drug-induced agranulocytosis].
    Federici L; Weitten T; Alt M; Blaison G; Zamfir A; Audhuy B; Maloisel F; Andrès E
    Presse Med; 2008 Sep; 37(9):1327-33. PubMed ID: 18644319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Idiosyncratic drug-induced agranulocytosis: the paradigm of deferiprone.
    Pontikoglou C; Papadaki HA
    Hemoglobin; 2010 Jun; 34(3):291-304. PubMed ID: 20524819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and management of drug-induced agranulocytosis.
    Andrès E; Zimmer J; Mecili M; Weitten T; Alt M; Maloisel F
    Expert Rev Hematol; 2011 Apr; 4(2):143-51. PubMed ID: 21495924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature.
    Andrès E; Kurtz JE; Maloisel F
    Clin Lab Haematol; 2002 Apr; 24(2):99-106. PubMed ID: 11985555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-Induced Idiosyncratic Agranulocytosis - Infrequent but Dangerous.
    Rattay B; Benndorf RA
    Front Pharmacol; 2021; 12():727717. PubMed ID: 34483939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors.
    van Staa TP; Boulton F; Cooper C; Hagenbeek A; Inskip H; Leufkens HG
    Am J Hematol; 2003 Apr; 72(4):248-54. PubMed ID: 12666135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of drug-induced agranulocytosis with haematopoietic growth factors: a review of the clinical experience.
    Vial T; Gallant C; Choqu-Kastylevsky G; Descotes J
    BioDrugs; 1999 Mar; 11(3):185-200. PubMed ID: 18031129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.